Polar Capital’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-50,000
Closed -$1.04M 271
2017
Q4
$1.04M Sell
50,000
-100,000
-67% -$2.08M 0.01% 242
2017
Q3
$2.65M Buy
150,000
+50,000
+50% +$884K 0.03% 216
2017
Q2
$1.13M Buy
100,000
+75,000
+300% +$848K 0.02% 225
2017
Q1
$320K Buy
+25,000
New +$320K ﹤0.01% 249